These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 19959490)

  • 1. Comparative studies on the topical administration of mucopolysaccharide and heparin ointments in nonhuman primates.
    Hoppensteadt DA; Neville B; Schultz C; Jeske W; Raake W; Fareed J
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):13-20. PubMed ID: 19959490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous release of tissue factor pathway inhibitor by topical application of an ointment containing mucopolysaccharide polysulfate to nonhuman primates.
    Hoppensteadt DA; Fareed J; Raake P; Raake W
    Thromb Res; 2001 Jul; 103(2):157-63. PubMed ID: 11457474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A primate model (Macaca mulatta) to study the pharmacokinetics of heparin and its fractions.
    Fareed J; Kumar A; Rock A; Walenga JM; Davis P
    Semin Thromb Hemost; 1985 Apr; 11(2):138-54. PubMed ID: 4035364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic effect of a mucopolysaccharide polysulfate after systemic, topical and percutaneous application.
    Görög P; Raake W
    Arzneimittelforschung; 1987 Mar; 37(3):342-5. PubMed ID: 2954557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profibrinolytic activity of the direct thrombin inhibitor melagatran and unfractionated heparin in platelet-poor and platelet-rich clots.
    Semeraro F; Piro D; Rossiello MR; Ammollo T; Colucci M
    Thromb Haemost; 2007 Dec; 98(6):1208-14. PubMed ID: 18064315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro.
    Hansen JB; Svensson B; Olsen R; Ezban M; Osterud B; Paulssen RH
    Thromb Haemost; 2000 Jun; 83(6):937-43. PubMed ID: 10896252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the antiphlogistic effect of mucopolysaccharide-polysulfate ointments with heparin-containing ointments in the UV erythema test].
    Raake W
    Arzneimittelforschung; 1984; 34(4):449-51. PubMed ID: 6234898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fucosylated chondroitin sulfate as a new oral antithrombotic agent.
    Fonseca RJ; Mourão PA
    Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant full-length tissue factor pathway inhibitor (TFPI) prevents thrombus formation and rethrombosis after lysis in a rabbit model of jugular vein thrombosis.
    Kaiser B; Fareed J
    Thromb Haemost; 1996 Oct; 76(4):615-20. PubMed ID: 8903005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heparin and mucopolysaccharide polysulfuric acid ester permeate human skin].
    Stüttgen G; Panse P; Bauer E
    Z Hautkr; 1989 Sep; 64(9):756, 761-2, 765. PubMed ID: 2530708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of anticoagulant and anti-inflammatory responses using enoxaparin versus unfractionated heparin for transesophageal echocardiography-guided cardioversion of atrial fibrillation.
    Hoppensteadt D; Fareed J; Klein AL; Jasper SE; Apperson-Hansen C; Lieber EA; Katz WE; Malouf JF; Stoddard MF; Pape LA;
    Am J Cardiol; 2008 Oct; 102(7):842-6. PubMed ID: 18805108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulatory effects of Escherichia coli capsular-derived sulfaminoheparosans and heparins on tissue factor-mediated activation of platelets: flow cytometric analysis.
    Maddineni J; Jeske WP; Baltasar F; Cornelli U; Manoni M; Hoppensteadt DA; Fareed J
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):311-7. PubMed ID: 16959684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.
    Kojima T; Gando S; Kemmotsu O; Mashio H; Goda Y; Kawahigashi H; Watanabe N
    J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):60-4. PubMed ID: 11254842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative anticoagulant and platelet modulatory effects of enoxaparin and sulodexide.
    Adiguzel C; Iqbal O; Hoppensteadt D; Jeske W; Cunanan J; Litinas E; He Zhu ; Walenga JM; Fareed J
    Clin Appl Thromb Hemost; 2009 Oct; 15(5):501-11. PubMed ID: 19703818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant effects and tissue factor pathway inhibitor after intrapulmonary low-molecular-weight heparin.
    Harenberg J; Malsch R; Angelescu M; Lange C; Michaelis HC; Wolf H; Heene DL
    Blood Coagul Fibrinolysis; 1996 Jun; 7(4):477-83. PubMed ID: 8840001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of total and free tissue factor pathway inhibitor (TFPI) as individual pharmacological parameters of various heparins.
    Alban S; Gastpar R
    Thromb Haemost; 2001 May; 85(5):824-9. PubMed ID: 11372675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of TFPI in clotting assays--comparison and combination with other anticoagulants.
    Nordfang O; Kristensen HI; Valentin S; Ostergaard P; Wadt J
    Thromb Haemost; 1993 Sep; 70(3):448-53. PubMed ID: 8259547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The present status of tissue factor pathway inhibitor.
    Lindahl AK; Sandset PM; Abildgaard U
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):439-49. PubMed ID: 1420819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of tissue factor pathway inhibitor (TFPI) in the HEPTEST assay and in an amidolytic anti factor Xa assay for LMW heparin.
    Kristensen HI; Ostergaard PB; Nordfang O; Abildgaard U; Lindahl AK
    Thromb Haemost; 1992 Sep; 68(3):310-4. PubMed ID: 1332210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fucoidan, as heparin, induces tissue factor pathway inhibitor release from cultured human endothelial cells.
    Giraux JL; Tapon-Bretaudière J; Matou S; Fischer AM
    Thromb Haemost; 1998 Oct; 80(4):692-5. PubMed ID: 9798992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.